Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

VE-1902—A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis

Thrombosis Research(2020)10.1016/j.thromres.2020.04.020Source: DataRank Database

VE-1902—A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis is a research paper published in Thrombosis Research (2020). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 1.11)OA: greenTopics (36)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (23)

Daniel M. Clemens,Sivan Sizikov,Subhadra Dash,Chengpei Xu,Matthew Rienzo ORCID

Live enrichment

PubMed:32339947 PMC:PMC7936662 OpenAlex:https://openalex.org/W3016940624

National Institutes of Health

Grant: HL049413

National Institutes of Health

Grant: HL139554

National Institutes of Health

Grant: HL147821

NHLBI NIH HHS

Grant: R01 HL049413

NHLBI NIH HHS

Grant: R01 HL147821

NHLBI NIH HHS

Grant: R29 HL049413

NHLBI NIH HHS

Grant: R01 HL139554

National Institutes of Health

Grant: 5R01HL139554-08

Structural enzymology of protein C

National Institutes of Health

Grant: 5R01HL147821-07

Structural enzymology of factor V activation

National Institutes of Health

Grant: 5R29HL049413-02

BIOPHYSICAL STUDIES OF THROMBIN

Verseon Corporation

FWCI

1.11

Citation Percentile

0.8%

Citation Trend

2021

2022

2023

2024

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7936662

publisherhttps://api.elsevier.com/content/article/PII:S0049384820301365?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0049384820301365?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.thromres.2020.04.020

Fields of Study

Atrial Fibrillation Management and OutcomesBlood Coagulation and Thrombosis MechanismsPlatelet Disorders and Treatments03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsAnticoagulantsAntithrombinsHemorrhageHumansRodentiaThrombinThrombosis

Keywords

ArgatrobanDirect thrombin inhibitorDiscovery and development of direct thrombin inhibitorsThrombinPharmacologyMedicineFibrinThrombosisDabigatranAntithrombinsLepirudinAntithromboticPlateletWarfarinInternal medicineImmunologyAtrial fibrillationAnticoagulantsReduced BleedingAnimalsHumansHemorrhageRodentia

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being